Yasuhito Tanaka

University Name

Japan

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

50%

Pharmacotherapy

40%

Hepatology

60%

Antiviral Therapy

40%

Hepatocellular Carcinoma

20%

Chemoprevention

20%

Hepatitis C

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Genome-wide research for identification of host factors associated with liver disease progression or improvement after hepatitis C virus eradication

Open Date: 2019-04-01

Close Date: 2021-03-01

Grant: Close

Drug screening for developing HBV therapeutics and optimization of the hit compounds

Open Date: 2017-04-01

Close Date: 2021-03-01

Articles11

Long-term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration.

Article Link

Year:

2023

Dried blood spot‐based host genome analysis technique targeting pathological associations with hepatitis B: Development and clinical application in the Cambodian population

Article Link

Year:

2023

Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment

Article Link

Year:

2023

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

Article Link

Year:

2023

Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma

Article Link

Year:

2023

Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase.

Article Link

Year:

2023

Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response.

Article Link

Year:

2023

Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study

Article Link

Year:

2023

Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study

Article Link

Year:

2023

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes.

Article Link

Year:

2023

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study

Article Link

Year:

2023

Collaborators5

Katsuya Nagaoka

Assistant Professor

Kumamoto University Hospital

JAPAN

Junko Tanaka

Prof and Chair/Head of medical School/

Hiroshima University

JAPAN

Hyungjin Eoh

Professor

University of Southern California

UNITED STATES

Masao Matsuoka

Kumamoto University

JAPAN

Takehisa Watanabe

Kumamoto University

JAPAN

How do I reach out?

Meet Kite AI